Systemic lupus erythematosus (SLE) is associated with premature atherosclerosis. Increasing arterial stiffness is closely associated with atherosclerotic cardiovascular diseases, and pulse wave velocity (PWV) is considered to be an indicator of arterial stiffness. The objective of this study was to identify the relationship between brachial-ankle pulse wave velocity (baPWV) and cardiovascular risk factors in patients with SLE. Age, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting blood glucose (FBS), plasma lipid profile, plasma homocysteine, thiobarbituric acid reactive substances (TBARS), baPWV, ankle-brachial index (ABI), and SLE-related factors were determined in a total of 83 SLE patients (12 males and 71 females). All SLE patients were further classified into two subgroups according to baPWV value (baPWV 1400 cm/s, n 37 versus baPWV 1400 cm/s, n 46). The mean baPWV value of studied SLE patients was 1520 381 cm/s. Age, BMI, SBP, DBP, FBS, TBARS and homocysteine levels were significantly higher in SLE patients with baPWV value 1400 cm/s than in SLE patients with baPWV value 1400 cm/s. In addition, baPWV correlated significantly with age, SBP, DBP, FBS and homocysteine. Moreover, stepwise multiple regression analysis showed that age and SBP were independently associated with baPWV. The results of this study indicate a possible link between vascular stiffness measured by baPWV and cardiovascular risk factors in patients with SLE.
Steinberg AD , Klinman DM.Pathogenesis of systemic lupus erythematosus . Rheum Dis Clin N Am1988; 14: 25-41 .
2.
Abu-Shakra M , Urowitz MB , Gladman DD , Gough J.Mortality studies in systemic lupus erythematosus: results from a single center. I. Causes of death . J Rheumatol1995; 22: 1259-1264 .
3.
Ward MM.Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus . Arthritis Rheum1999; 42: 338-346 .
4.
Laurent S , Boutouyrie P , Asmar Ret al.Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients . Hypertension2001; 37: 1236-1241 .
5.
Brodszki J , Bengtsson C , Lanne T , Nived O , Sturfelt G , Marsal K.Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus . Lupus2004; 13: 917-923 .
6.
Meaume S , Benetos A , Henry OF , Rudnichi A , Safar ME.Aortic pulse wave velocity predicts cardiovascular mortality in subjects 70 years of age . Arterioscler Thromb Vasc Biol2001; 21: 2046-2050 .
7.
Toto-Moukouo JJ , Achimastos A , Asmar RG , Hugues CJ , Safar ME.Pulse wave velocity in patients with obesity and hypertension . Am Heart J1986; 112: 136-140 .
8.
Muramatsu J , Kobayashi A , Hasegawa N , Yokouchi S.Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin . Atherosclerosis1997; 130: 179-182 .
9.
Airaksinen KE , Salmela PI , Linnaluoto MK , Ikaheimo MJ , Ahola K , Ryhanen LJ.Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen . Cardiovasc Res1993; 27: 942-945 .
10.
Blacher J , Asmar R , Djane S , London GM , Safar ME.Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients . Hypertension1999; 33: 1111-1117 .
11.
Yamashina A , Tomiyama H , Takeda Ket al.Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement . Hypertens Res2002; 25: 359-364 .
12.
Aso K , Miyata M , Kubo Tet al.Brachial-ankle pulse wave velocity is useful for evaluation of complications in type 2 diabetic patients . Hypertens Res2003; 26: 807-813 .
13.
Yokoyama H , Hirasawa K , Aoki T , Ishiyama M , Koyama K.Brachial-ankle pulse wave velocity measured automatically by oscillometric method is elevated in diabetic patients with incipient nephropathy . Diabet Med2003; 20: 942-945 .
14.
Choi KM , Lee KW , Seo JAet al.Relationship between brachial-ankle pulse wave velocity and cardiovascular risk factors of the metabolic syndrome . Diabetes Res Clin Pract2004; 66: 57-61 .
15.
Ohnishi H , Saitoh S , Takagi Set al.Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose: The Tanno and Sobetsu Study . Diabetes Care2003; 26: 437-440 .
16.
Munakata M , Ito N , Nunokawa T , Yoshinaga K.Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients . Am J Hypertens2003; 16: 653-657 .
17.
Imanishi R , Seto S , Toda Get al.High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men . Hypertens Res2004; 27: 71-78 .
18.
Selzer F , Sutton-Tyrrell K , Fitzgerald S , Tracy R , Kuller L , Manzi S.Vascular stiffness in women with systemic lupus erythematosus . Hypertension2001; 37: 1075-1082 .
19.
Tan EM , Cohen AS , Fries JFet al.The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum1982; 25: 1271-1277 .
20.
Yamashina A , Tomiyama H , Arai Tet al.Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk . Hypertens Res2003; 26: 615-622 .
21.
Friedewald WT , Levy RI , Fredrickson DS.Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge . Clin Chem1972; 18: 499-502 .
22.
Oteiza PI , Olin KL , Fraga CG , Keen CL.Zinc deficiency causes oxidative damage to proteins, lipids and DNA in rat testes . J Nutr1995; 125: 823-829 .
23.
Bombardier C , Gladman DD , Urowitz MBet al.Derivation of the SLEDAI: a disease activity index for lupus patients . Arthritis Rheum1992; 35: 630-640 .
24.
Chang DM , Lan JL , Lin HY , Luo SF.Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus . Arthritis Rheum2002; 46: 2924-2927 .
25.
Tso TK , Huang HY , Chang CK , Liao YJ , Huang WN.Clinical evaluation of insulin resistance and -cell function by the homeostasis model assessment in patients with systemic lupus erythematosus . Clin Rheumatol2004; 23: 416-420 .
26.
Sacks D , Bakal C , Beatty Pet al.Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease . J Vasc Interv Radiol2002; 13: 353-353 .
27.
Theodoridou A , Bento L , D’Cruz DP , Khamashta MA , Hughes GRV.Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study . Ann Rheum Dis2003; 62: 1199-1203 .
28.
Newman AB , Siscovick DS , Manolio TAet al.Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group . Circulation1993; 88: 837-845 .
29.
van Popele NM , Grobbee DE , Bots MLet al.Association between arterial stiffness and atherosclerosis: The Rotterdam Study . Stroke2001; 32: 454-460 .
30.
Tomiyama H , Yamashina A , Arai Tet al.Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12517 subjects . Atherosclerosis2003; 166: 303-309 .
31.
Manzi S , Meilahn EN , Rairie JEet al.Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study . Am J Epidemiol1997; 145: 408-415 .
32.
Petri M , Perez-Gutthann S , Spence D , Hochberg MC.Risk factors for coronary artery disease in patients with systemic lupus erythematosus . Am J Med1992; 93: 513-519 .
33.
Roman MJ , Shanker B , Davis Aet al.Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus . N Engl J Med2003; 349: 2399-2406 .
34.
Lyons TJ.Glycation and oxidation: a role in the pathogenesis of atherosclerosis . Am J Cardiol1993; 71: 26B-31B .
35.
Tso TK , Huang WN , Huang HY , Liao YJ.Effect of anticardiolipin antibody on lipoprotein oxidation and antioxidant enzyme activities in normalipidaemic patients with systemic lupus erythematosus . Ann Rheum Dis2004; 63 (Suppl I): 218-218 (abstract THU0368).
36.
Tso TK , Huang WN , Huang HY , Liao YJ.Oxidative status and antioxidant enzyme activities in patients with systemic lupus erythematosus . Ann Rheum Dis2004; 63 (Suppl I): 218-218 (abstract THU0369).
37.
Clarke R , Daly L , Robinson Ket al.Hyperhomocysteinemia: an independent risk factor for vascular disease . N Engl J Med1991; 324: 1149-1155 .
38.
Ueland PM , Refsum H , Beresford SAA , Vollset SE.The controversy over homocysteine and cardiovascular risk . Am J Clin Nutr2000; 72: 324-332 .
39.
Welch GN , Loscalzo JN.Homocysteine and atherothrombosis . N Engl J Med1998; 338: 1042-1050 .
40.
Hsu TS , Hsu LA , Chang CJet al.Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study . Thromb Res2001; 102: 387-395 .
41.
Boushey CJ , Beresford SAA , Omenn GS , Motulsky AG.A quantitative assessment of plasma homocysteine as a risk factor for vascular disease, probable benefits of increasing folic acid intakes . J Am Med Assoc1995; 274: 1049-1057 .
42.
den Heijer M , Koster T , Blom HJet al.Hyperhomocysteinemia as a risk factor for deep-vein thrombosis . N Engl J Med1996; 334: 759-762 .
43.
Refai TMK , Al-Salem IH , Nkansa-Dwamena D , Al-Salem MH.Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients . Clin Rheumatol2002; 21: 457-461 .
44.
Petri M , Roubenoff R , Dallal GEet al.Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus . Lancet1996; 348: 1120-1124 .
45.
Fijnheer R , Roest M , Haas FJet al.Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study . J Rheumatol1998; 25: 1737-1742 .
46.
Huang WN , Tso TK , Huang HY , Liao YJ.Association of homocysteine with PWV in patients with systemic lupus erythematosus . Ann Rheum Dis2004; 63 (Suppl I): 218-218 (abstract THU0370).
47.
Hossain GS , van Thienen JV , Werstuck GHet al.TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the development of atherosclerosis in hyperhomocysteinemia . J Biol Chem2003; 278: 30317-30327 .
48.
Zhang C , Cai Y , Adachi MTet al.Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response . J Biol Chem2001; 276: 35867-35874 .
49.
Buemi M , Marino D , Di Pasquale Get al.Effects of homocysteine on proliferation, necrosis and apoptosis of vascular smooth muscle cells in culture and influence of folic acid . Thromb Res2001; 104: 207-213 .
